NCT07465003尚未招募不适用
Use of Antimicrobial Drugs in Severe Infections and Epidemiological Study of Populations With Severe Infections
The Second Affiliated Hospital of Chongqing Medical University0 个研究点目标入组 1,600 人开始时间: 2026年2月25日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 1,600
- 主要终点
- 28-day all-cause mortality in cirrhosis with sepsis
研究概览
简要总结
Study population: Patients with liver cirrhosis complicated by sepsis Observation indicators: Fluid resuscitation strategy, early dynamic indicators such as MAP Observation endpoint: 28-day all-cause mortality Study design: Retrospective cohort study
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Clinically or pathologically diagnosed with cirrhosis;
- •meets the Sepsis-3 diagnostic criteria.
排除标准
- •Combined organ transplantation, active malignant tumors;
- •Pregnant or breastfeeding women;
- •Long-term use of immunosuppressants (non-steroidal);
- •Death or voluntary discharge within 24 hours of admission;
- •Incomplete data.
结局指标
主要结局
28-day all-cause mortality in cirrhosis with sepsis
时间窗: Baseline and 28 days.
次要结局
未报告次要终点
研究者
相似试验
尚未招募
不适用
study of how antibiotics opposing to action on different bacterial diseases.CTRI/2024/03/063923Mahavir institute of medical sciences300
尚未招募
不适用
Bacterial infectionCTRI/2024/04/066006Hasbiya137
招募中
2 期
Encapsulated Fecal Microbiota Transfer to Treat Immune Activation in Patients with Cirrhosis and Ascites (TransImmune) – A randomized, double-blind, placebo-controlled phase IIa clinical pilot study2023-507790-18-00Universitaetsklinikum Aachen AöR24
招募中
不适用
A study to predict the course of disease using alternative marker in patients with severe infectionCTRI/2024/02/062479Dr Sanchit Mittal140
招募中
不适用
ROLE OF PROBIOTICS ON MUSCLE WEAKNESS & MASS IN ADVANCED LIVER DISEASECTRI/2024/11/077055PGIMER102